Danny Bellens

771 citations
7 papers · 615 indexed · h-index 6

Impact in

    • Antifungal resistance and susceptibility
    • Pharmacogenetics and Drug Metabolism
    • Fungal Biology and Applications

Papers in

Danny Bellens

7 papers receiving 599 citations

Peers

Danny Bellens
Comparison fields: 5 of 66
  • Infectious Diseases 335
  • Pharmacology 105
  • Epidemiology 246
  • Pharmacology 100
  • Small Animals 36
Replace J. Gorrens with:
J. Gorrens Belgium
J.M. Van Cutsem Belgium
Andrew J. Corran United Kingdom
Kenneth F. Bartizal United States
C Lacave France
C Asselineau France
Grayson Hough United States
Raulo Parmegiani United States
Peter J. Brennan Australia
Juan Bueno Colombia
Danny Bellens relative to J. Gorrens Belgium J. Gorrens's profile →
Citations per field
00.5×1.7×
J. Gorrens · 1×
Citations per year

Countries citing papers authored by Danny Bellens

Since Specialization
Citations

This map shows the geographic impact of Danny Bellens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny Bellens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny Bellens more than expected).

Fields of papers citing papers by Danny Bellens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danny Bellens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny Bellens. The network helps show where Danny Bellens may publish in the future.

Co-authorship network

The 18 scholars most cited alongside Danny Bellens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Danny Bellens Line = papers co-authored together Danny Bellens links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1 20103
2 1999305
3 199217
4 199067
5 199095
6 199025
7 1987103

About Danny Bellens

Danny Bellens is a scholar working on Pharmacology, Infectious Diseases, Biochemistry, Small Animals and Pharmacology, having authored 7 papers that have together received 615 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Steroid Chemistry and Biochemistry (2 papers), Fungal Plant Pathogen Control (1 paper), Synthesis and biological activity (1 paper), Estrogen and related hormone effects (1 paper), Fungal Biology and Applications (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Infectious Diseases (335 citations), Pharmacology (105 citations), Epidemiology (246 citations), Pharmacology (100 citations) and Small Animals (36 citations). Danny Bellens has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include H. Vanden Bossche, Patrick Marichal, Paul A. J. Janssen, Μ. Borgers, Peter Verhasselt, Frans C.�S. Ramaekers, Luc Koymans, Frank C. Odds, Walter Luyten and J. Gorrens. Their work appears in journals such as Biochemical Pharmacology, Biochemical Society Transactions, Microbiology, ChemMedChem and Pesticide Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026